Skip to main content
Year archive

Heidelberg Pharma AG — 2020 filings

All 38 regulatory filings released by Heidelberg Pharma AG (HPHA) in 2020, sourced directly from the official regulator.

38 Filings
2020 Period
2020 filings (38)
Filing Released Lang
Heidelberg Pharma AG Receives Shareholder Loan Based on an Existing Financing Commitment
Capital/Financing Update
2020-12-21 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2020-11-30 English
Heidelberg Pharma will Present at German Equity Forum and Provides Update on Partner Activities for its Legacy Assets
Regulatory Filings
2020-11-12 English
Heidelberg Pharma Announces Several Presentations of Research Results on ATAC Technology at the ASH Annual Meeting 2020
Regulatory Filings
2020-11-05 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2020-10-30 English
Q3 statement / Q3 financial report 2019/2020
Interim / Quarterly Report FY 2020
2020-10-13 English
Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2020
Interim / Quarterly Report 9M 2020
2020-10-08 English
Quartalsfinanzbericht
Interim / Quarterly Report 9M 2020
2020-10-08 German
Heidelberg Pharma AG Announces Adjustment of Guidance
Earnings Release FY 2020
2020-09-29 English
Heidelberg Pharma Receives Milestone Payment from Partner Magenta
Regulatory Filings
2020-09-14 English
Heidelberg Pharma Announces Participation at Various Conferences
Regulatory Filings
2020-09-10 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2020-08-31 English
Heidelberg Pharma AG: Annual General Meeting 2020 of Heidelberg Pharma Approves All Proposed Resolutions
AGM Information
2020-07-22 English
Heidelberg Pharma AG: Main Shareholder dievini Commits to Further Financing for Expansion of Proprietary Pipeline
Capital/Financing Update
2020-07-21 English
Heidelberg Pharma AG: Heidelberg Pharma reports on first half-year 2020
Earnings Release H1 2020
2020-07-09 English
Datum:09.07.2020
Interim / Quarterly Report H1 2020
2020-07-09 German
Half-yearly financial report 2019/2020
Interim / Quarterly Report H2 2020
2020-07-09 English
Heidelberg Pharma to Present at the Upcoming Virtual European Biotech Investor Day 2020
Report Publication Announcement
2020-06-24 English
Heidelberg Pharma AG: Bekanntmachung der Einberufung zur Hauptversammlung am 22.07.2020 in Ladenburg mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2020-06-12 German
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-05-18 German
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-05-05 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2020-04-30 English
Heidelberg Pharma AG Raises EUR 14.4 Million From Private Placement
Share Issue/Capital Change
2020-04-27 English
Heidelberg Pharma AG Plans Capital Increase to Fund Its ATAC Development Program
Share Issue/Capital Change
2020-04-27 English
Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2020
Interim / Quarterly Report Q1 2020
2020-04-23 English
Datum:23.04.2020
Interim / Quarterly Report Q1 2020
2020-04-23 German
Q1 statement / Q1 financial report 2019/2020
Interim / Quarterly Report Q1 2020
2020-04-23 German
Datum:07.04.2020
Annual Report FY 2019
2020-04-07 German
Heidelberg Pharma AG: European Patent Office Grants Patent for Amatoxin Conjugates for Tumor Therapy
Report Publication Announcement
2020-03-31 English
Heidelberg Pharma Publishes Article on Chemical Amanitin Synthesis in Angewandte Chemie Journal
Regulatory Filings
2020-03-27 English
Heidelberg Pharma Announces Financial Figures for Fiscal Year 2019 and Provides Business Update
Earnings Release FY 2019
2020-03-19 English
Annual financial report 2018/2019
Annual Report FY 2019
2020-03-19 German
Report Publication Announcement 2020
Report Publication Announcement
2020-03-04 English
Heidelberg Pharma AG: US patent rights granted for diagnosis and treatment of patients with TP53/RNA polymerase II deletion
Legal Proceedings Report
2020-03-04 English
Hinweis auf Jahresfinanzbericht vom 01.12.2018 bis zum 30.11.2019
Report Publication Announcement
2020-03-04 German
Datum:04.03.2020
Report Publication Announcement
2020-03-04 German
Heidelberg Pharma AG: Partner Magenta Therapeutics Presents Preclinical Data on Lead Clinical Candidate MGTA-117 Demonstrating Broad Tolerability and High Therapeutic Index
Earnings Release FY 2020
2020-02-24 English
Heidelberg Pharma AG Secures Financing Commitment from Its Main Shareholder dievini
Capital/Financing Update
2020-01-22 English